Registro:

Referencias:

• Anderson, M.E., Woelker, B., Reed, M., Wang, P., Tegtmeyer, P., Reciprocal interference between the sequence-specific core and nonspecific C-terminal DNA binding domains of p53: Implications for regulation (1997) Mol Cell Biol, 17 (11), pp. 6255-6264
• Ando, T., Kawabe, T., Ohara, H., Ducommun, B., Itoh, M., Okamoto, T., Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage (2001) J Biol Chem, 276 (46), pp. 42971-42977
• Appella, E., Anderson, C.W., Post-translational modifications and activation of p53 by genotoxic stresses (2001) Eur J Biochem, 268 (10), pp. 2764-2772
• Asher, G., Shaul, Y., P53 Proteasomal degradation: Poly-ubiquitination is not the whole story (2005) Cell Cycle, 4 (8), pp. 229-232
• Bargonetti, J., Manfredi, J.J., Multiple roles of the tumor suppressor p53 (2002) Curr Opin Oncol, 14 (1), pp. 86-91
• Barlev, N.A., Liu, L., Chehab, N.H., Mansfield, K., Harris, K.G., Halazonetis, T.D., Berger, S.L., Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases (2001) Molecular Cell, 8 (6), pp. 1243-1254
• Bartek, J., Lukas, J., Mammalian G1- and S-phase checkpoints in response to DNA damage (2001) Curr Opin Cell Biol, 13 (6), pp. 738-747
• Bartek, J., Lukas, J., Pathways governing G1/S transition and their response to DNA damage (2001) FEBS Lett, 490 (3), pp. 117-122
• Bartek, J., Lukas, C., Lukas, J., Checking on DNA damage in S phase (2004) Nat Rev Mol Cell Biol, 5 (10), pp. 792-804
• Bensaad, K., Vousden, K.H., P53: New roles in metabolism (2007) Trends in Cell Biology, 17 (6), pp. 286-291
• Bischoff, J.R., Kirn, D.H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., McCormick, F., An adenovirus mutant that replicates selectively in p53- deficient human tumor cells (1996) Science, 274 (5286), pp. 373-376
• Bode, A.M., Dong, Z., Post-translational modification of p53 in tumorigenesis (2004) Nat Rev Cancer, 4 (10), pp. 793-805
• Bottger, A., Bottger, V., Sparks, A., Liu, W.L., Howard, S.F., Lane, D.P., Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo (1997) Curr Biol, 7 (11), pp. 860-869
• Brooks, C.L., Gu, W., Ubiquitination, phosphorylation and acetylation: The molecular basis for p53 regulation (2003) Curr Opin Cell Biol, 15 (2), pp. 164-171
• Brooks, C.L., Gu, W., P53 ubiquitination: Mdm2 and beyond (2006) Molecular Cell, 21 (3), pp. 307-315
• Carvajal, D., Tovar, C., Yang, H., Vu, B.T., Heimbrook, D.C., Vassilev, L.T., Activation of p53 by MDM2 antagonists can protect proliferating cells from mitotic inhibitors (2005) Cancer Res, 65 (5), pp. 1918-1924
• Charrier-Savournin, F.B., Chateau, M.T., Gire, V., Sedivy, J., Piette, J., Dulic, V., P21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress (2004) Mol Biol Cell, 15 (9), pp. 3965-3976
• Chuikov, S., Kurash, J.K., Wilson, J.R., Xiao, B., Justin, N., Ivanov, G.S., McKinney, K., Reinberg, D., Regulation of p53 activity through lysine methylation (2004) Nature, 432 (7015), pp. 353-360
• Crighton, D., Wilkinson, S., Ryan, K.M., DRAM links autophagy to p53 and programmed cell death (2007) Autophagy, 3 (1), pp. 72-74
• El-Deiry, W.S., Regulation of p53 downstream genes (1998) Semin Cancer Biol, 8 (5), pp. 345-357
• Espinosa, J.M., Mechanisms of regulatory diversity within the p53 transcriptional network (2008) Oncogene, 27 (29), pp. 4013-4023
• Fridman, J.S., Lowe, S.W., Control of apoptosis by p53 (2003) Oncogene, 22 (56), pp. 9030-9040
• Gottifredi, V., Prives, C., The S phase checkpoint: When the crowd meets at the fork (2005) Semin Cell Dev Biol, 16 (3), pp. 355-368
• Grossman, S.R., Deato, M.E., Brignone, C., Chan, H.M., Kung, A.L., Tagami, H., Nakatani, Y., Livingston, D.M., Polyubiquitination of p53 by a ubiquitin ligase activity of p300 (2003) Science, 300 (5617), pp. 342-344
• Gu, W., Roeder, R.G., Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain (1997) Cell, 90 (4), pp. 595-606
• Halaby, M.J., Yang, D.Q., P53 translational control: A new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics (2007) Gene, 395 (1-2), pp. 1-7
• Harris, C.C., P53 tumor suppressor gene: From the basic research laboratory to the clinic- an abridged historical perspective (1996) Carcinogenesis, 17 (6), pp. 1187-1198
• He, L., He, X., Lowe, S.W., Hannon, G.J., MicroRNAs join the p53 network-another piece in the tumour-suppression puzzle (2007) Nat Rev Cancer, 7 (11), pp. 819-822
• Ho, J.S., Ma, W., Mao, D.Y., Benchimol, S., P53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest (2005) Mol Cell Biol, 25 (17), pp. 7423-7431
• Hupp, T.R., Meek, D.W., Midgley, C.A., Lane, D.P., Regulation of the specific DNA binding function of p53 (1992) Cell, 71 (5), pp. 875-886
• Ito, A., Lai, C.H., Zhao, X., Saito, S., Hamilton, M.H., Appella, E., Yao, T.P., P300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2 (2001) Embo J, 20 (6), pp. 1331-1340
• Jackson, M.W., Agarwal, M.K., Agarwal, M.L., Agarwal, A., Stanhope-Baker, P., Williams, B.R., Stark, G.R., Limited role of N-terminal phosphoserine residues in the activation of transcription by p53 (2004) Oncogene, 23 (25), pp. 4477-4487
• Jin, S., Tong, T., Fan, W., Fan, F., Antinore, M.J., Zhu, X., Mazzacurati, L., Zhan, Q., GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity (2002) Oncogene, 21 (57), pp. 8696-8704
• Jin, Y., Zeng, S.X., Dai, M.S., Yang, X.J., Lu, H., MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation (2002) J Biol Chem, 277 (34), pp. 30838-30843
• Kaeser, M.D., Iggo, R.D., Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo (2002) Proc Natl Acad Sci USA, 99 (1), pp. 95-100
• Kawai, H., Nie, L., Wiederschain, D., Yuan, Z.M., Dual role of p300 in the regulation of p53 stability (2001) J Biol Chem, 276 (49), pp. 45928-45932
• Keller, D.M., Zeng, X., Wang, Y., Zhang, Q.H., Kapoor, M., Shu, H., Goodman, R., Lu, H., A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1 (2001) Molecular Cell, 7 (2), pp. 283-292
• Krummel, K.A., Lee, C.J., Toledo, F., Wahl, G.M., The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation (2005) Proc Natl Acad Sci USA, 102 (29), pp. 10188-10193
• Lane, D.P., Cancer. p53, guardian of the genome (1992) Nature, 358 (6381), pp. 15-16
• Levine, A.J., P53, the cellular gatekeeper for growth and division (1997) Cell, 88 (3), pp. 323-331
• Marine, J.C., Jochemsen, A.G., Mdmx and Mdm2: Brothers in arms? (2004) Cell Cycle, 3 (7), pp. 900-904
• McKinney, K., Mattia, M., Gottifredi, V., Prives, C., P53 linear diffusion along DNA requires its C terminus (2004) Molecular Cell, 16 (3), pp. 413-424
• Meek, D.W., Knippschild, U., Posttranslational modification of MDM2 (2003) Mol Cancer Res, 1 (14), pp. 1017-1026
• Meulmeester, E., Pereg, Y., Shiloh, Y., Jochemsen, A.G., ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation (2005) Cell Cycle, 4 (9), pp. 1166-1170
• Midgley, C.A., Desterro, J.M., Saville, M.K., Howard, S., Sparks, A., Hay, R.T., Lane, D.P., An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo (2000) Oncogene, 19 (19), pp. 2312-2323
• Mills, A.A., Zheng, B., Wang, X.J., Vogel, H., Roop, D.R., Bradley, A., P63 is a p53 homologue required for limb and epidermal morphogenesis (1999) Nature, 398 (6729), pp. 708-713
• Moll, U.M., Petrenko, O., The MDM2-p53 interaction (2003) Mol Cancer Res, 1 (14), pp. 1001-1008
• Montagnoli, A., Tenca, P., Sola, F., Carpani, D., Brotherton, D., Albanese, C., Santocanale, C., Cdc7 inhibition reveals a p53-dependent replication checkpoint that is defective in cancer cells (2004) Cancer Res, 64 (19), pp. 7110-7116
• Muller, S., Berger, M., Lehembre, F., Seeler, J.S., Haupt, Y., Dejean, A., C-Jun and p53 activity is modulated by SUMO-1 modification (2000) J Biol Chem, 275 (18), pp. 13321-13329
• Murphy, M.E., Polymorphic variants in the p53 pathway (2006) Cell Death Differ, 13 (6), pp. 916-920
• Murray-Zmijewski, F., Lane, D.P., Bourdon, J.C., P53/p63/p73 isoforms: An orchestra of isoforms to harmonise cell differentiation and response to stress (2006) Cell Death Differ, 13 (6), pp. 962-972
• Nghiem, P., Park, P.K., Kim Ys, Y.S., Desai, B.N., Schreiber, S.L., ATR is not required for p53 activation but synergizes with p53 in the replication checkpoint (2002) J Biol Chem, 277 (6), pp. 4428-4434
• Nyberg, K.A., Michelson, R.J., Putnam, C.W., Weinert, T.A., Toward maintaining the genome: DNA damage and replication checkpoints (2002) Annu Rev Genet, 36, pp. 617-656
• Oda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Taya, Y., P53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53 (2000) Cell, 102 (6), pp. 849-862
• Oliner, J.D., Pietenpol, J.A., Thiagalingam, S., Gyuris, J., Kinzler, K.W., Vogelstein, B., Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 (1993) Nature, 362 (6423), pp. 857-860
• Olsson, A., Manzl, C., Strasser, A., Villunger, A., How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? (2007) Cell Death Differ, 14 (9), pp. 1561-1575
• Oren, M., Decision making by p53: Life, death and cancer (2003) Cell Death Differ, 10 (4), pp. 431-442
• Ou, Y.H., Chung, P.H., Sun, T.P., Shieh, S.Y., P53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation (2005) Mol Biol Cell, 16 (4), pp. 1684-1695
• Paris, R., Henry, R.E., Stephens, S.J., McBryde, M., Espinosa, J.M., Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation (2008) Cell Cycle, 7 (15), pp. 2427-2433
• Pereg, Y., Shkedy, D., De Graaf, P., Meulmeester, E., Edelson-Averbukh, M., Salek, M., Biton, S., Shiloh, Y., Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage (2005) Proc Natl Acad Sci USA, 102 (14), pp. 5056-5061
• Piwnica-Worms, H., Cell Cycle (1999) Fools Rush In. Nature, 401 (6753), pp. 535-537
• Rieder, C.L., Maiato, H., Stuck in division or passing through: What happens when cells cannot satisfy the spindle assembly checkpoint (2004) Dev Cell, 7 (5), pp. 637-651
• Rodriguez, M.S., Desterro, J.M., Lain, S., Midgley, C.A., Lane, D.P., Hay, R.T., SUMO-1 modification activates the transcriptional response of p53 (1999) Embo J, 18 (22), pp. 6455-6461
• Sabbatini, P., McCormick, F., MDMX inhibits the p300/CBP-mediated acetylation of p53 (2002) DNA Cell Biol, 21 (7), pp. 519-525
• Saito, S., Goodarzi, A.A., Higashimoto, Y., Noda, Y., Lees-Miller, S.P., Appella, E., Anderson, C.W., ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation (2002) J Biol Chem, 277 (15), pp. 12491-12494
• Sakaguchi, K., Herrera, J.E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C.W., Appella, E., DNA damage activates p53 through a phosphorylation-acetylation cascade (1998) Genes Dev, 12 (18), pp. 2831-2841
• Schuler, M., Green, D.R., Transcription, apoptosis and p53: Catch-22 (2005) Trends Genet, 21 (3), pp. 182-187
• Selivanova, G., Kawasaki, T., Ryabchenko, L., Wiman, K.G., Reactivation of mutant p53: A new strategy for cancer therapy (1998) Semin Cancer Biol, 8 (5), pp. 369-378
• Shaulsky, G., Goldfinger, N., Tosky, M.S., Levine, A.J., Rotter, V., Nuclear localization is essential for the activity of p53 protein (1991) Oncogene, 6 (11), pp. 2055-2065
• Sherr, C.J., G1 phase progression: Cycling on cue (1994) Cell, 79 (4), pp. 551-555
• Sionov, R.V., Haupt, Y., The cellular response to p53: The decision between life and death (1999) Oncogene, 18 (45), pp. 6145-6157
• Stavridi, E.S., Chehab, N.H., Malikzay, A., Halazonetis, T.D., Substitutions that compromise the ionizing radiation-induced association of p53 with 14-3-3 proteins also compromise the ability of p53 to induce cell cycle arrest (2001) Cancer Res, 61 (19), pp. 7030-7033
• Stewart, Z.A., Pietenpol, J.A., P53 Signaling and cell cycle checkpoints (2001) Chem Res Toxicol, 14 (3), pp. 243-263
• Strano, S., Dellorso, S., Di Agostino, S., Fontemaggi, G., Sacchi, A., Blandino, G., Mutant p53: An oncogenic transcription factor (2007) Oncogene, 26 (15), pp. 2212-2219
• Taylor, W.R., Stark, G.R., Regulation of the G2/M transition by p53 (2001) Oncogene, 20 (15), pp. 1803-1815
• Taylor, W.R., Agarwal, M.L., Agarwal, A., Stacey, D.W., Stark, G.R., P53 inhibits entry into mitosis when DNA synthesis is blocked (1999) Oncogene, 18 (2), pp. 283-295
• Teodoro, J.G., Evans, S.K., Green, M.R., Inhibition of tumor angiogenesis by p53: A new role for the guardian of the genome (2007) J Mol Med (Berlin, Germany), 85 (11), pp. 1175-1186
• Thompson, T., Tovar, C., Yang, H., Carvajal, D., Vu, B.T., Xu, Q., Wahl, G.M., Vassilev, L.T., Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis (2004) J Biol Chem, 279 (51), pp. 53015-53022
• Vassilev, L.T., Vu, B.T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Liu, E.A., In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 (2004) Science, 303 (5659), pp. 844-848
• Vogel, C., Kienitz, A., Hofmann, I., Muller, R., Bastians, H., Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy (2004) Oncogene, 23 (41), pp. 6845-6853
• Vogelstein, B., Lane, D., Levine, A.J., Surfing the p53 network (2000) Nature, 408 (6810), pp. 307-310
• Vousden, K.H., P53: Death Star (2000) Cell, 103 (5), pp. 691-694
• Vousden, K.H., Lu, X., Live or let die: The cells response to p53 (2002) Nat Rev Cancer, 2 (8), pp. 594-604
• Wang, Y., Prives, C., Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases (1995) Nature, 376 (6535), pp. 88-91
• Wang, X.W., Zhan, Q., Coursen, J.D., Khan, M.A., Kontny, H.U., Yu, L., Hollander, M.C., Harris, C.C., GADD45 induction of a G2/M cell cycle checkpoint (1999) Proc Natl Acad Sci USA, 96 (7), pp. 3706-3711
• Wang, Y.H., Tsay, Y.G., Tan, B.C., Lo, W.Y., Lee, S.C., Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305 (2003) J Biol Chem, 278 (28), pp. 25568-25576
• Waterman, M.J., Stavridi, E.S., Waterman, J.L., Halazonetis, T.D., ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins (1998) Nat Genet, 19 (2), pp. 175-178
• Webley, K., Bond, J.A., Jones, C.J., Blaydes, J.P., Craig, A., Hupp, T., Wynford-Thomas, D., Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage (2000) Mol Cell Biol, 20 (8), pp. 2803-2808
• Xirodimas, D.P., Saville, M.K., Bourdon, J.C., Hay, R.T., Lane, D.P., Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity (2004) Cell, 118 (1), pp. 83-97
• Yang, A., McKeon, F., P63 and P73: P53 mimics, menaces and more (2000) Nat Rev Mol Cell Biol, 1 (3), pp. 199-207
• Zhu, Y., Alvarez, C., Doll, R., Kurata, H., Schebye, X.M., Parry, D., Lees, E., Intra-S-phase checkpoint activation by direct CDK2 inhibition (2004) Mol Cell Biol, 24 (14), pp. 6268-6277

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------